Glassman Wealth Services’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 2005 |
|
2022
Q3 | $0 | Sell |
2
-328
| -99% | – | ﹤0.01% | 1881 |
|
2022
Q2 | $19K | Buy |
330
+327
| +10,900% | +$18.8K | ﹤0.01% | 644 |
|
2022
Q1 | $0 | Sell |
3
-2
| -40% | – | ﹤0.01% | 1847 |
|
2021
Q4 | $1K | Sell |
5
-57
| -92% | -$11.4K | ﹤0.01% | 1434 |
|
2021
Q3 | $17K | Sell |
62
-21
| -25% | -$5.76K | ﹤0.01% | 632 |
|
2021
Q2 | $21K | Buy |
83
+21
| +34% | +$5.31K | ﹤0.01% | 562 |
|
2021
Q1 | $18K | Sell |
62
-7
| -10% | -$2.03K | ﹤0.01% | 556 |
|
2020
Q4 | $18K | Buy |
69
+21
| +44% | +$5.48K | ﹤0.01% | 560 |
|
2020
Q3 | $12K | Buy |
48
+27
| +129% | +$6.75K | ﹤0.01% | 574 |
|
2020
Q2 | $7K | Buy |
21
+20
| +2,000% | +$6.67K | ﹤0.01% | 561 |
|
2020
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1407 |
|
2019
Q3 | – | Sell |
-1
| Closed | – | – | 1266 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1268 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1151 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 908 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 910 |
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 900 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 641 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 750 |
|